International journal of general medicine · 2026
Comprehensive Analysis of the Expression and Prognostic Significance of NPAS1 in Patients with Colorectal Adenocarcinoma Based on Bioinformatics.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Bai Miaoyu, Hu Keyi, Cui Jitao, Xia Qingqing, Li Jie, Wang Wenwei, Liu Binghui, Zhu Xudong, Ye Qigang
Аннотация
BACKGROUND: Neuronal PAS domain protein 1 (NPAS1) is a protein-coding gene expressed mainly in the central nervous system and plays a key role in nervous system development. The expression and prognostic value of NPAS1 in colorectal adenocarcinoma (COAD) are unknown.
METHODS: The expression and clinicopathological data of COAD from Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) were analyzed. NPAS1 gene expression in colon cancer tissues was validated by Western blotting and immunohistochemical staining. Function and immune infiltration were established using Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), Gene Set Enrichment Analysis (GSEA), and single sample Gene Set Enrichment Analysis (ssGSEA). Methylation levels were analyzed utilizing the UALCAN database. NPAS1-related mutations were analyzed using cBioPortal. Single-cell and tissue-specific expression of NPAS1 was examined using the Human Protein Atlas. Protein-protein interactions and transcription factor networks of NPAS1-associated genes were analyzed with STRING and Network Analyst.
RESULTS: Our study found that the expression level of NPAS1 was higher in normal tissues compared to COAD tissues, higher NPAS1 expression was associated with better survival outcomes. The bioinformatics analysis confirmed that NPAS1 co-expressed genes were linked to diverse signalling pathways and cellular functions. NPAS1 is correlated with CD56bright, cytotoxic and NK cells, and negatively correlated with helper T cells and Tcm cells. The DNA methylation level of NPAS1 in tumor tissues was elevated compared to normal tissues. We analyzed the mutation characteristics of NPAS1, single-cell expression profiling of NPAS1, and protein-protein interactions involving genes associated with NPAS1. These discoveries offered perspectives on the etiology, identification, and management of COAD.
CONCLUSION: This study revealed a significant decrease of NPAS1 expression in COAD tissues, exhibiting associations with the clinical stage, prognosis, immune infiltration, and DNA methylation of COAD.
METHODS: The expression and clinicopathological data of COAD from Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) were analyzed. NPAS1 gene expression in colon cancer tissues was validated by Western blotting and immunohistochemical staining. Function and immune infiltration were established using Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), Gene Set Enrichment Analysis (GSEA), and single sample Gene Set Enrichment Analysis (ssGSEA). Methylation levels were analyzed utilizing the UALCAN database. NPAS1-related mutations were analyzed using cBioPortal. Single-cell and tissue-specific expression of NPAS1 was examined using the Human Protein Atlas. Protein-protein interactions and transcription factor networks of NPAS1-associated genes were analyzed with STRING and Network Analyst.
RESULTS: Our study found that the expression level of NPAS1 was higher in normal tissues compared to COAD tissues, higher NPAS1 expression was associated with better survival outcomes. The bioinformatics analysis confirmed that NPAS1 co-expressed genes were linked to diverse signalling pathways and cellular functions. NPAS1 is correlated with CD56bright, cytotoxic and NK cells, and negatively correlated with helper T cells and Tcm cells. The DNA methylation level of NPAS1 in tumor tissues was elevated compared to normal tissues. We analyzed the mutation characteristics of NPAS1, single-cell expression profiling of NPAS1, and protein-protein interactions involving genes associated with NPAS1. These discoveries offered perspectives on the etiology, identification, and management of COAD.
CONCLUSION: This study revealed a significant decrease of NPAS1 expression in COAD tissues, exhibiting associations with the clinical stage, prognosis, immune infiltration, and DNA methylation of COAD.